(FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 3.79%259.86M | 6.50%198.2M | 7.92%128.36M | -1.83%59M | 35.74%250.36M | --186.1M | 39.72%118.93M | --60.1M | 46.60%184.44M | 68.04%85.13M |
Operating income | 3.79%259.86M | 7.92%128.36M | 35.74%250.36M | 39.72%118.93M | 46.60%184.44M | 68.04%85.13M | ||||
Cost of sales | -12.59%-181.46M | ---- | -19.58%-89.37M | ---- | -36.88%-161.17M | ---- | -34.74%-74.73M | ---- | -39.62%-117.74M | -53.98%-55.46M |
Operating expenses | -12.59%-181.46M | -19.58%-89.37M | -36.88%-161.17M | -34.74%-74.73M | -39.62%-117.74M | -53.98%-55.46M | ||||
Gross profit | -12.11%78.39M | -11.79%38.99M | 33.72%89.19M | 49.02%44.2M | 60.78%66.7M | 102.62%29.66M | ||||
Selling expenses | -13.63%-8.18M | ---- | -16.07%-3.99M | ---- | -25.83%-7.2M | ---- | -23.51%-3.44M | ---- | -12.89%-5.72M | -41.57%-2.79M |
Administrative expenses | -0.27%-44.55M | ---- | -5.77%-22.88M | ---- | -35.81%-44.43M | ---- | -55.55%-21.63M | ---- | -73.76%-32.72M | -56.07%-13.9M |
Research and development expenses | -55.46%-6.04M | ---- | -97.79%-3.14M | ---- | -59.57%-3.88M | ---- | -64.35%-1.59M | ---- | -32.21%-2.43M | -28.50%-965K |
Impairment and provision | -210.50%-1.86M | ---- | -59.15%-487K | ---- | 22.38%-600K | ---- | 15.70%-306K | ---- | -809.41%-773K | -142.00%-363K |
-Goodwill impairment | ---1.89M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairment is provision | 105.00%30K | ---- | -59.15%-487K | ---- | 22.38%-600K | ---- | 15.70%-306K | ---- | -809.41%-773K | -142.00%-363K |
Special items of operating profit | -44.48%3.72M | ---- | 9.73%2.14M | ---- | 160.02%6.71M | ---- | 88.33%1.95M | ---- | -57.87%2.58M | -70.28%1.04M |
Operating profit | -45.99%21.49M | -44.58%10.64M | 43.97%39.79M | 51.36%19.19M | 26.85%27.64M | 99.69%12.68M | ||||
Financing cost | -79.13%-7.07M | ---- | -119.79%-3.11M | ---- | -53.08%-3.95M | ---- | -16.94%-1.42M | ---- | -17.44%-2.58M | -15.90%-1.21M |
Share of profits of associates | -36.96%162K | ---- | -177.78%-119K | ---- | 2,755.56%257K | ---- | --153K | ---- | 113.24%9K | ---- |
Earning before tax | -59.62%14.58M | -58.69%7.41M | 44.00%36.1M | 56.32%17.93M | 28.40%25.07M | 116.78%11.47M | ||||
Tax | 62.25%-3.85M | ---- | 40.99%-2.85M | ---- | -65.95%-10.2M | ---- | -100.25%-4.83M | ---- | -191.60%-6.14M | -189.09%-2.41M |
After-tax profit from continuing operations | -58.58%10.73M | -65.21%4.56M | 36.88%25.9M | 44.63%13.1M | 8.65%18.92M | 103.25%9.06M | ||||
Earning after tax | -58.58%10.73M | -65.21%4.56M | 36.88%25.9M | 44.63%13.1M | 8.65%18.92M | 103.25%9.06M | ||||
Minority profit | -148.48%-80K | ---- | -121.66%-34K | ---- | -66.60%165K | ---- | -29.60%157K | ---- | 86.42%494K | 284.48%223K |
Profit attributable to shareholders | -58.00%10.81M | -54.84%9.8M | -64.53%4.59M | -118.37%-900K | 39.65%25.74M | 21.7M | 46.50%12.95M | 4.9M | 7.45%18.43M | 100.86%8.84M |
Basic earnings per share | -57.94%0.0053 | -63.49%0.0023 | 40.00%0.0126 | 46.51%0.0063 | 5.88%0.009 | 95.45%0.0043 | ||||
Diluted earnings per share | -57.72%0.0052 | -63.93%0.0022 | 41.38%0.0123 | 45.24%0.0061 | 4.82%0.0087 | 100.00%0.0042 | ||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
Auditor | -- | -- | -- | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | -- | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data